5F-ADB-PINACA is a cannabinoid designer drug that is an ingredient in some synthetic cannabis products. It is a potent agonist of the CB1 receptor and CB2 receptor with EC50 values of 0.24 nM and 2.1 nM respectively.
AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University.
Buy 5f-SGT-151 Online
5F-SGT-151 or 5F-CUMYL-PeGaCLONE are the abbreivated names for 5-fluoropentyl-2-(1-methyl-1-phenyl-ethyl)-2,5-dihydro-pyrido[4,3-b]indol-1-one, which is one of the new generation of novel synthetic cannabinoids, that is uncontrolled at present in most of the EU for use in laboratory research.
Buy AKB-57 online
AKB-57 is a commonly utilized compound amongst professional chemists. The compound was created with the intention of being used as a replacement for the chemical AKB-48. This makes AKB-57 a more refined version of that chemical, being generally more efficient and predictable.
FUB-AKB48 Cannabinoid for sale online
FUB-APINACA (also known as AFUBINACA and FUB-AKB48) is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. It is an analog of APINACA and 5F-APINACA where the pentyl chain has been replaced with fluorobenzyl.
AMB-FUBINACA is a synthetic indabole cannabinoid which is a potent cannabinoid receptor agonist, with Kᵢ values of 10.04 nM at CB₁ and 0.786 nM at CB₂ and EC₅₀ values of 0.5433 nM at CB₁ and 0.12278 nM at CB₂, and is sold online as a synthetic drug.
MAB-CHMINACA is an indazole-based synthetic cannabinoid (CB) structurally similar to AB-CHMINACA, both of which have been found in herbal blend products and are classified as Schedule I substances by the US Drug Enforc…
NM-2201 (also known as CBL-2201) is an indole-based synthetic cannabinoid that presumably has similar properties to the closely related 5F-PB-22 and NNE1, which are both full agonists and unselectively bind to CB1 and CB2 receptors with low nanomolar affinity